MarketsStocksSENORES
SE

Senores Pharmaceuticals Ltd

NSE: SENORESBSE: 544319Healthcare
Download Research Report7-page PDF
1,005.00
-2.87%
NSE · auto-updates while market open
Prev Close
₹532.90
Day High
₹1,049.30
Day Low
₹1,001.00
Mkt Cap
₹4,596 Cr
P / E
37.8
P / B
4.9
ROE
14.1%
52W High
₹1,194.40
52W Low
₹512.75
Key Metrics
Market Cap
₹4,596 Cr
P / E
37.81
P / B
4.92
EV / EBITDA
29.30
ROCE
15.7%
ROE
14.1%
Debt / Equity
0.35
Book Value
₹202.74
EPS
₹26.39
Div Yield
0.0%
Face Value
-
Promoter Holding
45.8%
Revenue · ₹ Cr
398
FY25
633
FY26
Net Profit · ₹ Cr
58
FY25
122
FY26
EPS · ₹ per share
₹16.1
FY25
₹26.4
FY26
P / E Ratio · price ÷ TTM EPS
2834414830140-2Apr 25Aug 25Jan 26Jun 26
P/E 38.2×Median 36.5×TTM EPS
Q1 2026 snapshot
Sales
₹193 Cr
Operating profit
-
OPM
-
Net profit
₹37 Cr
EPS
₹7.96
Scorecard · 7 axes
Quality
Good
72/100
Valuation
Avg
37.8×
Growth
-
Profitability
Avg
14.9%
Performance
Strong
+96.8%
Entry Point
Avg
84%
Red Flags
Strong
0 flags
Shareholding Pattern
45.8%Promoter
Promoter45.8%
FII3.6%
DII9.6%
Public40.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue103.018125.98141.35167.17178.34192.86
Net Profit16.42917.9721.1830.1233.5836.67
NPM %15.9%14.3%15.0%18.0%18.8%19.0%
AlertPre-trade